Published in Indian J Pharmacol on August 01, 2008
Role of pharmacogenetics in public health and clinical health care: a SWOT analysis. Eur J Hum Genet (2016) 0.79
Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany. Adv Ther (2016) 0.75
CYP2C9*3 polymorphism presenting as lethal subdural hematoma with low-dose warfarin. Indian J Pharmacol (2014) 0.75
The price of innovation: new estimates of drug development costs. J Health Econ (2003) 23.43
The druggable genome. Nat Rev Drug Discov (2002) 13.61
Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A (2000) 10.27
The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. N Engl J Med (1998) 3.97
Pharmacogenetics and the practice of medicine. Nature (2000) 3.68
Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov (2006) 3.40
Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest (1997) 2.85
Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9. Pharmacogenetics (1994) 2.55
High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med (1998) 2.30
Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest (1995) 2.17
Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues. J Thromb Thrombolysis (2007) 2.12
Progress in high throughput SNP genotyping methods. Pharmacogenomics J (2002) 1.88
Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer. Herceptin Multinational Investigator Study Group. Semin Oncol (1999) 1.58
The cost of new drug discovery and development. Discov Med (2004) 1.21
The pharmacogenetics of CYP2C9 and CYP2C19: ethnic variation and clinical significance. Curr Clin Pharmacol (2007) 1.17
The apolipoprotein epsilon4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction : a substudy of the Scandinavian simvastatin survival study. Circulation (2000) 1.13
Pharmacogenetics of irinotecan: clinical perspectives on the utility of genotyping. Pharmacogenomics (2006) 1.11
The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder. Psychopharmacology (Berl) (2003) 1.09
The role of pharmacogenetics in cancer therapeutics. Br J Clin Pharmacol (2006) 1.06
The candidate gene approach. Alcohol Res Health (2000) 1.00
Angiotensinogen gene haplotype and hypertension: interaction with ACE gene I allele. Hypertension (2003) 0.97
Regression of left ventricular hypertrophy by lisinopril after renal transplantation: role of ACE gene polymorphism. Kidney Int (2000) 0.94
Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapy. Atherosclerosis (1995) 0.93
In vitro approaches can predict human drug metabolism. Trends Pharmacol Sci (1993) 0.92
Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis. Am J Cardiol (1999) 0.92
Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease. BMC Med Genet (2007) 0.91
Pharmacogenetics in drug development. Philos Trans R Soc Lond B Biol Sci (2005) 0.91
Pharmacogenetic application in drug development and clinical trials. Drug Metab Dispos (2001) 0.89
Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders. J Child Adolesc Psychopharmacol (2007) 0.85
Drug target pharmacogenomics: an overview. Am J Pharmacogenomics (2001) 0.85
Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5-HTTLPR-S) and the CYP2C9*3 allele. Fundam Clin Pharmacol (2007) 0.84
Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors. Am J Med (1999) 0.83
Angiotensin-converting enzyme gene polymorphism and reversibility of uremic left ventricular hypertrophy following long-term antihypertensive therapy. Kidney Int (1998) 0.80
Application of pharmacogenomics in clinical pharmacology. Toxicol Mech Methods (2006) 0.78
UGT1A1 polymorphism predicts irinotecan toxicity: evolving proof. AAPS PharmSci (2001) 0.78
A case report of a patient carrying CYP2C9*3/4 genotype with extremely low warfarin dose requirement. J Korean Med Sci (2007) 0.77
The impact of FDA guidance on pharmacogenomic data submissions on drug development. IDrugs (2005) 0.77
A case of intolerance to warfarin dosing in an intermediate metabolizer of CYP2C9. Yonsei Med J (2005) 0.77
Influence of the CYP2C9 AND CYP2C19 polymorphisms on phenytoin hydroxylation in healthy individuals from south India. Indian J Med Res (2006) 2.30
Changing pattern of antimicrobial utilization in an Indian teaching hospital. Int J Clin Pharmacol Ther Toxicol (1990) 1.48
Association of aldosterone synthase (CYP11B2 C-344T) gene polymorphism & susceptibility to essential hypertension in a south Indian Tamil population. Indian J Med Res (2010) 1.47
CYP2D6 genotype and phenotype relationship in South Indians. J Postgrad Med (2006) 1.41
Recurrent femoral pseudoaneurysm following intravenous opioid abuse: a case report. J Indian Med Assoc (2000) 1.39
Drug utilization at primary health care level in southern India. Eur J Clin Pharmacol (1992) 1.34
A comparative study of saliva and serum paracetamol levels using a simple spectrophotometric method. Br J Clin Pharmacol (1982) 1.31
Adverse drug reaction profile of cisplatin-based chemotherapy regimen in a tertiary care hospital in India: An evaluative study. Indian J Pharmacol (2010) 1.21
Association of polymorphisms in apolipoprotein A1 and apolipoprotein B genes with lipid profile in Tamilian population. Indian Heart J (2009) 1.19
The pharmacogenetics of CYP2C9 and CYP2C19: ethnic variation and clinical significance. Curr Clin Pharmacol (2007) 1.17
A study of adverse drug reactions in pediatric patients. J Pharmacol Pharmacother (2011) 1.14
Apolipoprotein AI and Apolipoprotein B gene polymorphisms and lipid profile in Tamilian population. Ann Hum Biol (2009) 1.07
Training medical professionals on the concepts of essential drugs and rational drug use. Br J Clin Pharmacol (1994) 1.07
Genetic polymorphisms of CYP2C19 influences the response to clopidogrel in ischemic heart disease patients in the South Indian Tamilian population. Eur J Clin Pharmacol (2012) 1.05
Hepatoprotective activity of six polyherbal formulations in paracetamol induced liver toxicity in mice. Indian J Med Res (2009) 0.98
Genetic polymorphisms of drug-metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population. Fundam Clin Pharmacol (2011) 0.96
Hepatoprotective activities of picroliv, curcumin, and ellagic acid compared to silymarin on carbon-tetrachloride-induced liver toxicity in mice. J Pharmacol Pharmacother (2012) 0.92
Antimicrobial resistance in India: A review. J Nat Sci Biol Med (2013) 0.91
Genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) and upper aerodigestive tract cancer risk among smokers, tobacco chewers and alcoholics in an Indian population. Eur J Cancer (2007) 0.91
CYP2E1 polymorphisms and gene-environment interactions in the risk of upper aerodigestive tract cancers among Indians. Pharmacogenomics (2008) 0.91
Cholesteryl ester transfer protein TaqIB, -629C>A and I405V polymorphisms and risk of coronary heart disease in an Indian population. Clin Chim Acta (2009) 0.90
Distribution of CYP2C19*17 allele and genotypes in an Indian population. J Clin Pharm Ther (2011) 0.87
Genetic polymorphisms of CYP2E1 and GSTP1 in a South Indian population--comparison with North Indians, Caucasians and Chinese. Asian Pac J Cancer Prev (2005) 0.86
Novel applications of nanotechnology in medicine. Indian J Med Res (2009) 0.85
Assessment of sympathovagal imbalance by spectral analysis of heart rate variability in prehypertensive and hypertensive patients in Indian population. Clin Exp Hypertens (2011) 0.85
The effect of the CYP2C19 genotype on the hydroxylation index of omeprazole in South Indians. Eur J Clin Pharmacol (2005) 0.84
Common variants of Cholesteryl ester transfer protein gene and their association with lipid parameters in healthy volunteers of Tamilian population. Clin Chim Acta (2006) 0.84
Sympathovagal Imbalance in Prehypertensive Offspring of Two Parents versus One Parent Hypertensive. Int J Hypertens (2011) 0.84
Gly460Trp polymorphism of the ADD1 gene and essential hypertension in an Indian population: A meta-analysis on hypertension risk. Indian J Hum Genet (2010) 0.84
Glutathione S-transferase M1 and T1 null genotype distribution in South Indians. Eur J Clin Pharmacol (2004) 0.83
Chronic psychiatric patients: an assessment of treatment and rehabilitation-related needs. Int J Rehabil Res (2000) 0.82
Genetic polymorphism of CYP2D6 in Karnataka and Andhra Pradesh population in India. Acta Pharmacol Sin (2000) 0.81
Role of ventromedial hypothalamus on energy homeostasis in albino rats: effect of gender. Indian J Physiol Pharmacol (2013) 0.81
Effect of short surgical procedures on salivary paracetamol elimination. Br J Clin Pharmacol (1985) 0.81
Seasonal variation in amylase, invertase, cellulase activity and carbon dioxide evolution in a tropical protected grassland of Orissa, India, sprayed with carbaryl insecticide. Environ Pollut (1987) 0.81
IgG subclass response and protection against challenge following immunisation of mice with various influenza A vaccines. J Med Microbiol (1994) 0.80
Influence of CYP2C9 gene polymorphisms on response to glibenclamide in type 2 diabetes mellitus patients. Eur J Clin Pharmacol (2011) 0.80
Genetic polymorphism of drug refractory epilepsy. Indian J Med Res (2011) 0.80
P-glycoprotein expression as a predictor of response to neoadjuvant chemotherapy in breast cancer. Indian J Cancer (2013) 0.79
Genetic polymorphism of CYP2D6 in a keralite (South India) population. Br J Clin Pharmacol (2000) 0.79
Drug therapy in elderly. J Assoc Physicians India (2008) 0.79
Effect of honey on carbamazepine kinetics in rabbits. Indian J Exp Biol (2002) 0.78
The creatinine clearance rate in malnutrition and in cirrhosis of the liver. Indian J Med Sci (1981) 0.78
Effect of two types of Indian breakfast on bioavailability of cefuroxime axetil. Indian J Med Res (2000) 0.78
Preference for salt contributes to sympathovagal imbalance in the genesis of prehypertension. Eur J Clin Nutr (2013) 0.78
Genetic polymorphism of CYP2D6 in Tamil population. Eur J Clin Pharmacol (2001) 0.78
Drug utilisation study of antimicrobial agents. Indian J Med Res (1981) 0.78
Study of sympathovagal imbalance by spectral analysis of heart rate variability in young prehypertensives. Indian J Physiol Pharmacol (2013) 0.78
Alphamethyldopa analgesia: its possible mechanism of action. Arch Int Pharmacodyn Ther (1985) 0.77
Increased vascular tone due to sympathovagal imbalance in normotensive and prehypertensive offspring of hypertensive parents. Int Angiol (2012) 0.77
Influence of honey on orally and intravenously administered diltiazem kinetics in rabbits. Indian J Exp Biol (2002) 0.77
The beginning and end of psychiatric pathways. Br J Psychiatry (1999) 0.75
Lipids and schizophrenia. Br J Psychiatry (1999) 0.75
Polymorphic variants of beta1 adrenergic receptor gene (Ser49Gly & Arg389Gly) in healthy Tamilian volunteers. Indian J Med Res (2010) 0.75
Plasma antioxidants and schizophrenia. Schizophr Res (2000) 0.75
Gold versus silver: the issue of functional versus symptomatic recovery in depression. J Clin Psychiatry (2000) 0.75
Smoking cessation and major depression. Lancet (2001) 0.75
Clozapine-induced urinary incontinence: facts or artefacts? Acta Psychiatr Scand (2000) 0.75
Compensated hypothyroidism. Postgrad Med J (1999) 0.75
Substance misuse in first-episode psychosis. Br J Psychiatry (2000) 0.75
Rehabilitation needs of institutionalized patients. Acta Psychiatr Scand (1998) 0.75
Adverse drug reactions--how common to quinolones? Indian J Physiol Pharmacol (1996) 0.75
Evaluation of simplified antipyrine tests in plasma. Indian J Med Res (1988) 0.75
Effect of short course chemotherapy on salivary paracetamol elimination. Clin Exp Pharmacol Physiol (1988) 0.75
Pharmacokinetics of phenylbutazone in chronic liver disease. Indian J Med Res (1980) 0.75
Effect of propranolol on task performance in human volunteers. Indian J Med Res (1983) 0.75
Short term anti-tubercular drug therapy and hepatic microsomal enzyme activity. Antipyrine metabolism as an index. J Assoc Physicians India (1990) 0.75
Rabies antibody titers in vaccinees: protection, failure and prospects. Int J Clin Pharmacol Ther Toxicol (1992) 0.75
Fluoxetine-induced tremors. J Assoc Physicians India (1999) 0.75
Comparative bioavailability of two brands of ciprofloxacin: an Indian study. Int J Clin Pharmacol Ther Toxicol (1992) 0.75
Cortisol status in different types of leprosy. J Dermatol (1995) 0.75
Amitriptyline analgesia: tolerance & cross tolerance pattern. Indian J Med Res (1986) 0.75
Prevalence of mental and behavioural disorders in India : a meta-analysis. Indian J Psychiatry (1999) 0.75
Paracetamol elimination in patients with tricuspid regurgitation without cardiac failure. Indian J Physiol Pharmacol (1989) 0.75
Effect of halothane anaesthesia on salivary elimination of paracetamol. Eur J Clin Pharmacol (1986) 0.75
Relationship between free fatty acids & protein binding of acetyl salicylic acid in rats. Indian J Med Res (1984) 0.75
Studies on histamine and histaminase in spring catarrh (vernal conjunctivitis). Int Arch Allergy Appl Immunol (1981) 0.75
Pharmacokinetics of single dose oral digoxin in patients with uncomplicated type II diabetes mellitus. Int J Clin Pharmacol Ther Toxicol (1992) 0.75
Azithromycin-induced hiccups. J Postgrad Med (2008) 0.75
Drug abuse with a difference. J Assoc Physicians India (1999) 0.75
Salivary paracetamol elimination in patients with congestive cardiac failure. Clin Exp Pharmacol Physiol (1987) 0.75
Chemical composition of sal fruit (Shorea robusta). Indian Vet J (1967) 0.75
Cutaneous rhinosporidiosis in a patient of lepromatous leprosy--a case report. Indian J Lepr (1987) 0.75
Genetic variants of beta(1)-adrenoceptor gene polymorphisms (Ser49Gly and Arg389Gly) and essential hypertension in a south Indian Tamil population. Clin Exp Pharmacol Physiol (2008) 0.75
Do mast cell degranulators release prostaglandins from frog atria? Eur J Pharmacol (1982) 0.75
Atropine-induced rhabdomyolysis: an uncommon and potentially fatal adverse drug reaction. J Postgrad Med (2010) 0.75
Local anaesthetic activity of N-methyl hexahydro-9-methyl indeno (2,1-C) pyridine (M5) Indian J Physiol Pharmacol (1983) 0.75
Effect of alpha-Methyldopa on Physostigmine induced pressor response in rats. Indian J Exp Biol (1982) 0.75
Assessment of ascorbic acid status as revealed by lingual test. Indian J Physiol Pharmacol (1982) 0.75
Ampicillin pharmacokinetics in Indian geriatric subjects. Indian J Med Sci (1990) 0.75
Effect of vitamin K in hen's diet on hatchability. Indian Vet J (1967) 0.75
Potentiation of clonidine analgesia by amitriptyline. Indian J Exp Biol (1986) 0.75
Altered pharmacokinetics of lignocaine after epidural injection in type II diabetics. Eur J Clin Pharmacol (1992) 0.75
Analysis of human glutathione S-transferase alpha 1 (hGSTA1) gene promoter polymorphism using denaturing high performance liquid chromatography (DHPLC). Clin Chim Acta (2011) 0.75
Why patients prefer referral hospitals. World Health Forum (1991) 0.75
Antipyrine metabolism in patients with diabetes mellitus. Clin Exp Pharmacol Physiol (1983) 0.75
Effect of acute starvation on protein binding of phenylbutazone in rats. Indian J Med Res (1983) 0.75